Cybin Inc Revenue per Employee (CYBN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Cybin Inc   (NYSEAMER: CYBN)
 

Cybin Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Cybin Inc 's Revenue per employee fell on a trailing twelve month basis to $ 5,304,933, but the productivity of Cybin Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 4 other companies have achieved higher revenue per employee. While Cybin Inc 's total ranking has deteriorated compared to the previous quarter from to 175. Cybin Inc has 30 employees.


What is Sales per Employee Ratio?







CYBN Revenue per Employee (Jun 30 2026)
I. Quarter
(Mar 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
Y / Y Revenue Change - 123.74 % - - -
Sales per Employee (TTM) $ 5,304,933 5,304,933 2,371,000 2,371,000 2,371,000
CYBN's Total Ranking # 175 # # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 5
Overall Market # 175

Revenue per Employee Statistics
High Average Low
$ 5,304,933 $ 3,837,966 $ 2,371,000
(Mar 31 2025)   (Mar 31 2024)



Financial Statements
Cybin Inc 's Revenue MRQ $ 0 Millions Visit CYBN's Income Statement
Cybin Inc 's Revenues TTM $ 159 Millions Visit CYBN's aggregate revenue growth
What are CYBN's Sales? Visit CYBN's Sales by Segment




Other Ratios
Cybin Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CYBN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CYBN's Competitors
Revenue per Employee for CYBN's Suppliers
Revenue per Employee for CYBN's Customers

You may also want to know
CYBN's Sales Growth Rates CYBN's Pe Price to earnings ratio CYBN's Receivables Turnover Ratio CYBN's Stock Quote
CYBN's Net Income Growth Rates CYBN's Ps Price to Sales ratio CYBN's Sales per Employee CYBN's Asset Turnover Ratio
CYBN's Net Margin CYBN's Pb Price to Book ratio CYBN's Financial Strength Ratios CYBN's Dividend Payout Ratio
Date modified: 2026-10-08T16:46:10+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Agilon Health Inc   6,915,905.37 $ 5,920.015  Million 856 
Ligand Pharmaceuticals Incorporated  6,181,744.68 $ 290.542  Million 47 
Anika Therapeutics Inc   5,779,523.81 $ 121.370  Million 21 
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Amgen Inc   2,930,384.62 $ 38,095.000  Million 13,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.